Transpact Enterprises Past Earnings Performance
Past criteria checks 0/6
Transpact Enterprises has been growing earnings at an average annual rate of 44.3%, while the Healthcare industry saw earnings growing at 28.3% annually. Revenues have been growing at an average rate of 47.6% per year.
Key information
44.3%
Earnings growth rate
48.9%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 47.6% |
| Return on equity | -20.5% |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Transpact Enterprises makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 0 | -1 | 0 | 0 |
| 31 Dec 23 | 2 | -1 | 1 | 0 |
| 30 Sep 23 | 4 | -1 | 1 | 0 |
| 30 Jun 23 | 4 | -1 | 1 | 0 |
| 31 Mar 23 | 4 | -1 | 1 | 0 |
| 31 Dec 22 | 3 | 0 | 1 | 0 |
| 30 Sep 22 | 2 | 0 | 0 | 0 |
| 30 Jun 22 | 2 | -1 | 0 | 0 |
| 31 Mar 22 | 2 | -2 | 0 | 0 |
| 31 Dec 21 | 1 | -2 | 0 | 0 |
| 30 Sep 21 | 0 | -2 | 0 | 0 |
| 30 Jun 21 | 0 | -1 | 0 | 0 |
| 31 Mar 21 | 0 | -1 | 0 | 0 |
| 31 Dec 20 | 0 | -1 | 0 | 0 |
| 30 Sep 20 | 0 | -1 | 0 | 0 |
| 30 Jun 20 | 0 | -3 | 0 | 0 |
| 31 Mar 20 | 0 | -4 | 0 | 0 |
| 31 Dec 19 | 0 | -7 | 0 | 0 |
| 31 Mar 19 | 1 | -3 | 0 | 0 |
| 31 Mar 18 | 0 | -1 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
Quality Earnings: 542765 is currently unprofitable.
Growing Profit Margin: 542765 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 542765 is unprofitable, but has reduced losses over the past 5 years at a rate of 44.3% per year.
Accelerating Growth: Unable to compare 542765's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 542765 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.6%).
Return on Equity
High ROE: 542765 has a negative Return on Equity (-20.54%), as it is currently unprofitable.